Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).
about
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaAntimicrobial stewardship in paediatricsMethodology in improving antibiotic implementation policiesA Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in HospitalsOptimizing Antibiotic Stewardship in Nursing Homes: A Narrative Review and Recommendations for ImprovementAntimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipOutpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklistsRemote Antimicrobial Stewardship in Community HospitalsDelays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital studyKnowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobialsAntimicrobial resistance in hospital-acquired gram-negative bacterial infections.Antimicrobial stewardship: philosophy versus practice.Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.The impact of a Massachusetts state-sponsored educational program on antimicrobial stewardship in acute care hospitalsCurrent State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States.New and developing diagnostic technologies for urinary tract infections.Measurement of adult antimicrobial drug use in tertiary care hospital using defined daily dose and days of therapy.The Whole Price of Vancomycin: Toxicities, Troughs, and TimeContribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan.Frequency of outpatient antibiotic prescription on discharge to hospice care.Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospitalComparison of prior authorization and prospective audit with feedback for antimicrobial stewardship.Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States.Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retroEvaluation of early implementations of antibiotic stewardship program initiatives in nine Dutch hospitals.Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.Antimicrobial stewardship - can we afford to do without it?The Belgian policy of funding antimicrobial stewardship in hospitals and trends of selected quality indicators for antimicrobial use, 1999-2010: a longitudinal study.Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infectionsBloodstream infections in community hospitals in the 21st century: a multicenter cohort study.Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review.Implementation of antimicrobial stewardship policies in U.S. hospitals: findings from a national surveyNew in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time.Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.Empirical antibiotic therapy for pneumonia in intensive care units: a multicentre, retrospective analysis of potentially pathogenic microorganisms identified by endotracheal aspirates cultures.Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration
P2860
Q24601746-863E3C9F-BC77-4F68-A10E-B61E94EFBF43Q26740379-E8373499-82D5-4799-9ABC-0333DB0FCF96Q26744801-D053658E-88D6-43B8-9D1C-456CFCF5CC6EQ26749534-7394AADA-0463-4F88-9C4F-85F8349D2F1FQ26796478-781F01C6-73BD-4466-A9B2-F3D467C020B9Q28068503-5D9993B8-3A0A-4A0F-989E-5AF2CEADF0FFQ28088622-F6F8F008-A8F3-46FC-8ED8-477B1B1A5DE5Q28274417-4D29DFC5-A25E-4A25-B098-A71B25F3AD0BQ28534034-0D337E44-6B93-49BC-914D-AEE2635D1C17Q28651700-13CE3857-DA27-42D4-95FF-32CDD5C1D3CFQ30300006-A9C134E0-4F7D-4B7B-B9AB-4A661F3ADCC7Q30367226-69AEA604-F94F-4E23-BC80-8F4AEE793DD7Q30647100-AAA01D7A-FBC7-4804-AD31-FB43D51C4F5BQ33773288-EED45970-2981-47AF-83DE-04B229775722Q33782852-D1FDBD7C-13FB-4256-BA90-47D18C13F1A0Q33806235-D25D575B-56AD-4712-AD94-C69DF63C0174Q33877785-13A44AE7-3674-455A-A760-177CC552D4C2Q33885191-4564C3F2-F677-4AB3-BAA9-6E3775278022Q34046002-E62DFE6B-A24E-4F51-881A-DB98B8ACC79BQ34057375-308C7706-573C-4134-B2E9-F574DA9E019AQ34243748-FCB06D1C-EF42-4902-A8FA-B2BE73EA5D6DQ34343376-2E9E6879-943A-4249-8C41-90D6C4A312A1Q34403874-D9F6B051-0972-4BC4-8B2B-CEF61769A89AQ34468680-E1E5EF3F-AC8E-4DC4-9E97-91801F9598BDQ34491926-48EB0C2D-5FE9-47B6-8069-6D2A6EB5341CQ34514304-A8749246-840B-47C5-8353-687F1C01812EQ34670717-0CD09CDF-1F75-4B02-9C4B-32FEF06932B3Q34871254-834B33A1-D402-4064-96E3-76017BCC8DB8Q35023684-70C0E9EA-9C33-431C-90E3-71DD6D24260FQ35088891-17B435C6-E74B-4C39-9AA5-31663439DD4BQ35105971-84AFD436-ABC1-4B02-92C7-13EDBC6E2504Q35124358-040CF570-2DE5-4DFB-8498-F4093486E8B1Q35164922-92B6FC30-400D-425B-8A06-220F132E2BF3Q35166921-96934615-C211-4A90-8A2B-741B5BB7F430Q35616211-1E0DDC45-46AA-4101-B448-BA0135A70A1CQ35686514-38DDB1E2-FF29-40F9-8D23-A65CCA59559FQ35887408-1E56C326-2399-4600-AA04-8EE4A51DBEEDQ36053985-BCCD5619-43DF-4128-9AAA-5E867B7B6D63Q36167408-A83877EC-5182-448D-80D4-AEDA735F787AQ36455347-6DF08D3F-FB86-40BF-A0FF-1AA1B4EF7329
P2860
Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@ast
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@en
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@nl
type
label
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@ast
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@en
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@nl
prefLabel
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@ast
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@en
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@nl
P2860
P50
P356
P1476
Policy statement on antimicrob ...... tious Diseases Society (PIDS).
@en
P2093
Pediatric Infectious Diseases Society
P2860
P304
P356
10.1086/665010
P50
P577
2012-04-01T00:00:00Z